🇺🇸 FDA
Patent

US 9987377

Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

granted A61KA61K2039/523A61K39/3955

Quick answer

US patent 9987377 (Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells) held by EnGeneIC Molecular Delivery Pty Ltd expires Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
EnGeneIC Molecular Delivery Pty Ltd
Grant date
Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 31 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/523, A61K39/3955, A61K47/6901, A61K48/00